AlphaCore Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
AlphaCore Capital's PFE Position: Q1 2026 in Review
AlphaCore Capital increased its Pfizer (PFE) stake by 4% in Q1 2026, buying an estimated $175K and bringing the position to 170,924 shares worth $4.8M. The position accounts for 0.11% of the portfolio, ranked #162.
AlphaCore Capital first reported a position in PFE in Q4 2019 and has held it in 19 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- AlphaCore Capital held 170,924 shares of Pfizer worth $4.8M as of Q1 2026.
- AlphaCore Capital bought 6,556 Pfizer shares in Q1 2026, an estimated $175K.
- Pfizer made up 0.11% of AlphaCore Capital's portfolio in Q1 2026, its #162 holding.
- AlphaCore Capital first reported a position in Pfizer in Q4 2019 and has held it in 19 quarters since.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on AlphaCore Capital's 13F filing for Q1 2026, filed 15 May 2026.